Comparing DCP and DAP for Pemphigus Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

December 15, 2021

Study Completion Date

December 15, 2021

Conditions
Pemphigus Vulgaris
Interventions
DRUG

Dexamethasone Cyclophosphamide Pulse therapy

33 patients were enrolled in DCP group. They were given Dexamethasone Cyclophosphamide pulse therapy for 6 months and successful treatment outcome was assessed using Pemphigus Disease Area Index (PDAI) scores.

DRUG

Dexamethasone Azathioprine Pulse therapy

33 patients were enrolled in DAP group. They were given Dexamethasone Azathioprine pulse therapy for 6 months and successful treatment outcome was assessed using Pemphigus Disease Area Index (PDAI) scores.

Trial Locations (1)

75510

Jinnah Postgraduate Medical Center, Karachi

All Listed Sponsors
lead

Jinnah Postgraduate Medical Centre

OTHER_GOV